ALB and metabolic disease: In the multivariable analyses, underlying metabolic disorders (adjusted hazard ratio [aHR], 2.85; 95% CI, 1.01–8.07) and serum albumin <3.5 g/dL (aHR, 2.26; 95% CI, 1.29–3.96) were risk factors for DILI during ATT.